Because there are high-risk types of HPV that can potentially lead to cancer of the cervix and other body parts, many health experts are repeatedly warning the public to get an HPV vaccination. At present, there are three HPV vaccines (for females and males) approved by the FDA, which are:1,2
• Gardasil: Licensed in 2006, this HPV vaccine contains high-risk HPV types 16 and 18 that are linked to genital cancers and low-risk HPV types 6 and 11 that may cause genital warts. It’s approved for use in females and males ages 9 to 26 years old as a routine vaccination.
• Cervarix: It contains HPV types 16 and 18, and was licensed in 2009. Cervarix is approved for females ages 9 to 25 years old.
• Gardasil 9: Licensed in 2015, it contains the original Gardasil HPV types 16, 18, 6 and 11 in addition to types 31, 33, 45, 52 and 58, which are associated with cervical, vulvar, vaginal and anal cancers. Gardasil 9 is approved for males and females ages 9 to 26.
But here’s the problem with the HPV vaccine: Not only is there a growing concern regarding its efficiency and protective effects, but it’s also connected with thousands of reports of dangerous health risks, including deaths — reports that were being discussed in medical journals as early as 2009.3
HPV Vaccine Side Effects Are Alarming
There is a growing body of medical research that shows how the HPV vaccine causes nervous and immune system disorders in perfectly healthy girls and young women. In 2009, investigators reported that the U.S. Vaccine Adverse Events Reporting System (VAERS) showed 28 reports of anaphylaxis already reported after receipt of Gardasil, with 25 cases occurring on the same day as vaccination.
Other serious events included Guillain-Barre syndrome, transverse myelitis, motor neuron disease, venous thromboembolic events and deaths. Yet, investigators discounted the reports as nothing more than something to continue monitoring because “VAERS data must be interpreted cautiously and cannot generally be used to infer causal association [with the vaccine].”4
However, eight years later, a 2017 study released in the journal Drug Safety, conducted by a World Health Organization monitoring center based in Sweden, revealed the adverse event reports linked to the HPV vaccine have only increased. According to their data, the vaccine has a tendency to produce clusters of severe side effects that include:5
• Complex regional pain syndrome (CRPS)
• Postural orthostatic tachycardia syndrome (POTS)
• Chronic fatigue syndrome (CFS)
Still another study published in the European Journal of Neurology described how six healthy females developed POTS within six days to two months after receiving the HPV vaccination.6 These health problems are believed to be immune-mediated inflammatory neurodegenerative disorders, meaning that something in the vaccine is prompting the immune system to overreact in a detrimental, and sometimes fatal, way.
Gardasil May Adversely Affect Girls’ Fertility
A different report published in the Journal of Investigative Medicine in 2014, described cases of premature ovarian failure — aka premature menopause — in three girls who had received Gardasil. The report added that post-licensure, VAERS had also recorded 104 cases of amenorrhea (discontinuation of menses) following vaccination with Gardasil. Noting that the vaccine’s clinical studies had several shortfalls, the study’s authors said:7
“Underrepresentation of the vaccine’s target age group, incomplete and short-term follow-up, definitional limitations, hormone usage, fortnight restrictions of vaccine report card documentation and the decision not to report new medical conditions [such as ovarian failure or amenorrhea] as adverse events which occurred post month seven from first vaccination compromised safety studies’ observation of ovarian health.”
This report led the American College of Pediatricians (ACPEDS) to issue a statement urging pediatricians to discuss these possible adverse events with their patients before administering Gardasil.8
“The overwhelming majority (76 percent) of VAERS reports since 2006 with ovarian failure, premature menopause and/or amenorrhea are associated solely with Gardasil,” the statement said, noting that, “ … [T]he essential lack of saline placebos and the majority of the [clinical studies’] participants taking contraceptives in those studies preclude meaningful data to rule out an effect on ovarian function.”
Interestingly, the pediatricians’ declaration came following a presentation at the 18th World Congress on Controversies in Obstetrics, Gynecology & Infertility in October 2013, which detailed reports of menstrual disturbances and premature ovarian failure in young girls who had received Gardasil. That report concluded:9
“Pre-clinical, clinical and post-licensure safety studies of HPV4 were unable to evaluate ovarian safety. This matter needs to be resolved, since a potential compromise of future ovarian function could have serious implications for population health and fecundity.”
Thousands of Adverse Events Reported
In fact, by 2015 the HPV vaccine Gardasil had already led to over 35,000 adverse reaction reports to the U.S. government — and that included over 200 deaths.10 According to the National Vaccine Information Center:11
“Using the MedAlerts search engine, as of Sept. 30, 2015, there were a total of 37,474 vaccine reaction reports made to the federal Vaccine Adverse Events Reporting System (VAERS) associated with Gardasil vaccinations, including 209 deaths.
There were a total of 3,119 vaccine adverse reaction reports made to VAERS associated with Cervarix vaccinations, including 16 deaths. (Merck’s Gardasil vaccine, which was the first HPV vaccine licensed in the U.S., has the majority of the HPV vaccine market in the U.S.).”
This is alarming, considering that 118 million girls worldwide have received at least one dose of HPV (the numbers are still growing),12 as this vaccine has already been introduced in the immunization schedule of at least 74 countries.13
Worth noting is that reported adverse events with this vaccine concerned Japanese officials so much that the country’s health minister rescinded recommendation for the HPV vaccine in 2013. Stopping short of outright banning it, the minster “instructed local governments not to promote the use” of it while safety studies were ongoing.14
Lawsuits followed in July 2016, filed by dozens of Japanese girls who claimed they suffered ongoing health problems “ranging from headache, nausea and fatigue to loss of memory and numbness in their hands and legs,” due to the vaccine.15
Getting Vaccinated May Actually Increase Your Risk of Other HPV Infections and, Ironically, Cancer
Aside from its safety, the efficacy of HPV vaccine has been questionable even from the start. For example, a systematic review of pre- and post-licensure HPV vaccine trials, conducted by University of British Columbia experts, concluded that the vaccine’s effectiveness is both overstated and unproven.16
The researchers noted that they found “evidence of selective reporting of results from clinical trials,” and that the claims of the vaccine’s safety profile is “only supported by highly flawed design of safety trials.”17 Additionally, a recent review of seropositivity — which is measured by antibody titers for specific vaccine-relevant HPVs — of the three vaccines shows that both Gardasil and Gardasil9 have a loss of antibody titers for high-risk HPV 18 after just 24 months.
While all three vaccines show that they can protect you from acquiring vaccine-specific HPVs, NONE of them work for HPVs that you are positive for at the time of your vaccination. They also do not clear you from a present infection; they are only designed to protect against vaccine-relevant HPVs that you are NOT presently infected with.18
But what’s really alarming about this vaccine is that it may potentially increase your risk of infection from other HPVs — and subsequently, even cancer.
While vaccine proponents insist that genotype replacement won’t happen, at least two analyses suggest that type replacement is, indeed, possible in vaccinated individuals, with one study showing that two possible high-risk types (53 and 73) may break through.19 The second study showed that certain HPV types are already “shifting” from low-risk to high-risk in the wake of the vaccines.20
There are also suspicions that the HPV vaccine may, ironically, increase your chances of cervical cancer, if you are actively infected upon receiving the vaccine. This information was given by Merck and presented to the FDA prior to the vaccine’s approval.21 Even so, and despite the fact that the vaccine doesn’t work against HPVs you are presently positive for, the CDC does not recommend being tested for HPV before you get the vaccine.22
The HPV Vaccine Is Unnecessary as Long as You Get Regular Pap Smears
HPV is a very common virus, and some people do not even know that they have (or had) it. In fact, 90 percent23 of HPV infections actually resolve themselves within two years of infection, without causing any symptoms.24 There is only a very little percent of HPV infections that become chronic, and this is usually seen in individuals with high risk factors, such as an HIV infection, immunosuppression or having multiple sex partners.
As long as you get regular pap smear screenings, though, the risk of HPV becoming cervical cancer is very minimal. Pap testing can help detect precancerous cervical lesions, so they can be properly treated. Just getting this regular screening test already helped significantly reduce the rates of cervical cancer in many developed countries, and is a far better option than getting the HPV vaccine.
• Oral HPV
• HPV Test
• HPV FAQ